Cullinan Therapeutics, Inc.

CGEM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 18, 2026 4
4 Jun 18, 2026 4
4 Jun 18, 2026 4
4 Jun 18, 2026 4
4 Jun 18, 2026 4
8-K Jun 16, 2026 8-K
8-K Jun 10, 2026 8-K
8-K Jun 8, 2026 8-K
8-K May 18, 2026 8-K
SCHEDULE 13G/A May 15, 2026
10-Q May 7, 2026 10-Q
8-K May 7, 2026 8-K
4 May 6, 2026 4
144 May 5, 2026
S-3ASR Apr 28, 2026 S-3ASR
DEFA14A Apr 28, 2026 DEFA14A
DEF 14A Apr 28, 2026 DEF 14A
ARS Apr 28, 2026 ARS
SCHEDULE 13G/A Mar 26, 2026
S-8 Mar 10, 2026 S-8
10-K Mar 10, 2026 10-K
8-K Mar 10, 2026 8-K
4 Mar 9, 2026 4
144 Mar 5, 2026
SCHEDULE 13G Mar 4, 2026
← Newer Page 2 of 19 · 471 filings Older →